Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Endostar Plus EGFR-TKI（Epidermal Growth Factor Receptor-Tyrosine-Kinase Inhibitor） as a Treatment of EGFR Mutation-positive NSCLC

Zaiwen Fan · 2017
ClinicalTrials.gov · Datasets · License: Public Domain · 2017
Open Source ↗
egfrlungcancer
advanced cancer, lung cancer, nonsmall cell, egfr-tki, recombinant human endostatin, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 864625
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.